Understand the efficacy and safety of RINVOQ, a once-daily oral JAK inhibitor, for the treatment of active psoriatic arthritis (PsA) in adult TNFi-IR patients.
Understand the efficacy and safety of RINVOQ, a once-daily oral JAK inhibitor, for the treatment of active psoriatic arthritis (PsA) in adult TNFi-IR patients.
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.
A first biologic disease-modifying antirheumatic drug showed similar efficacy among psoriatic arthritis patients with a low number of affected joints as among those with a high number.
The findings of a recent study suggest that menopause, particularly early menopause, may increase the risk of developing rheumatoid arthritis in women.
The findings of a recent study suggest that menopause, particularly early menopause, may increase the risk of developing rheumatoid arthritis in women.
